Redx Pharma (REDX) News Today → America’s worst nightmare? (From Porter & Company) (Ad) Free REDX Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 1, 2024 | markets.businessinsider.comRedx Pharma Plc Shares now trading on JP JenkinsApril 30, 2024 | marketbeat.comRedx Pharma (LON:REDX) Stock Price Up 31.6%Redx Pharma (LON:REDX) Shares Up 31.6%April 20, 2024 | msn.comRedx boss scooped up shares after revealing London Stock Exchange exitApril 19, 2024 | insidertrades.comRedx Pharma Plc (LON:REDX) Insider Lisa Anson Buys 115,000 SharesApril 13, 2024 | morningstar.comRedx Pharma PLC REDXApril 13, 2024 | thetimes.co.ukExodus from Aim leaves chorus of questions in its wakeApril 13, 2024 | insidertrades.comInsider Buying: Redx Pharma Plc (LON:REDX) Insider Acquires 399,000 Shares of StockApril 10, 2024 | msn.comLondon markets are broken and closed, says pharma bossApril 10, 2024 | msn.comIs the London Stock Exchange’s AIM in terminal decline?April 7, 2024 | ft.comThe Lex Newsletter: The UK has a two-speed market problemApril 3, 2024 | ft.comDo not blame London for this latest stock market departureApril 2, 2024 | thetimes.co.ukRedX Pharma blames finance constraints for quitting stock marketApril 2, 2024 | msn.comPharma Redx is latest firm to delist from AIMApril 2, 2024 | uk.investing.comSterling ticks up as UK manufacturing recoversApril 2, 2024 | lse.co.ukAIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delistApril 2, 2024 | msn.comLondon loses another listed company as pharma riser goes privateApril 2, 2024 | msn.comFTSE 100 Live 2 April: Blue-chips in surprise jump to top 8000, near record high; house prices dip in MarchApril 2, 2024 | lse.co.ukRedx Pharma plummets on plans to delist from AIMMarch 8, 2024 | finance.yahoo.comRedx Pharma achieves milestone with dosing of first participant in Phase 1 clinical trial for RXC008February 14, 2024 | marketwatch.comRedx Pharma Says Not Involved in U.S.-Listing ProcessFebruary 14, 2024 | msn.comRedx Pharma denies US listing plan following reportFebruary 13, 2024 | morningstar.comRedx Pharma PLC 0RXFebruary 8, 2024 | finance.yahoo.comJAZZ Boosts Oncology Pipeline With KRAS Inhibitor ProgramFebruary 8, 2024 | finance.yahoo.comRedx Pharma lands biggest deal to date with sale of KRAS inhibitor programme to Jazz PharmaFebruary 7, 2024 | thetimes.co.ukRedx Pharma seals $880m cancer research partnershipFebruary 7, 2024 | lse.co.ukRedx Pharma Share ChatFebruary 7, 2024 | finanznachrichten.deJazz Pharmaceuticals plc: Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor ProgramFebruary 7, 2024 | finance.yahoo.comJazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor ProgramNovember 18, 2023 | finance.yahoo.comRedx Pharma Plc (REDX.L)November 6, 2023 | reuters.comBRIEF-Redx Pharma Unveils Preclinical Data From Rxc009October 20, 2023 | msn.comSMALL CAP MOVERS: Redx Pharma achieves successful £14m fundraiseOctober 19, 2023 | finance.yahoo.comRedx Pharma has "a lot to be excited about" after successful fundraiseOctober 18, 2023 | msn.comRedx Pharma announces plans to raise around £14m to progress pipelineOctober 18, 2023 | lse.co.ukRedx Pharma looks to progress portfolio after raising GBP14.1 millionOctober 18, 2023 | marketwatch.comRedx Pharma Raises GBP14.1 Mln to Progress PipelineOctober 6, 2023 | finance.yahoo.comRedx Pharma's (LON:REDX) investors will be pleased with their impressive 272% return over the last five yearsSeptember 27, 2023 | msn.comAvalyn raises $175m in funding to develop inhaled IPF drugsAugust 29, 2023 | msn.comFDA sees potential in zelasudil for the treatment of idiopathic pulmonary fibrosisAugust 21, 2023 | msn.comMARKET REPORT: Indivior shares rise after £24m Suboxone handoutAugust 21, 2023 | lse.co.ukRedx Pharma says RXC007 receives orphan drug designation from US FDAAugust 21, 2023 | marketwatch.comRedx Pharma Lung Disease Treatment Receives US FDA Orphan Drug DesignationJuly 10, 2023 | lse.co.ukRedx Pharma extends term of outstanding notes with two lenders to 2024May 17, 2023 | marketwatch.comRedx Pharma 1H Pretax Loss Widens on Falling Revenue, Higher CostsMay 17, 2023 | lse.co.ukRedx Pharma half-year loss doubles amid costs of failed Jounce mergerApril 17, 2023 | finance.yahoo.comInvestors in Redx Pharma (LON:REDX) have made a fantastic return of 404% over the past five yearsApril 3, 2023 | benzinga.comTermination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plcMarch 27, 2023 | thetimes.co.ukRedx deal fails after rival backs outMarch 27, 2023 | marketwatch.comRedx Pharma Shares Fall After Jounce Pulls Out of MergerMarch 27, 2023 | msn.comDrug developer Redx Pharma's $425m merger with Jounce Therapeutics off after takeover agreedMarch 27, 2023 | finance.yahoo.comJounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights Get Redx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for REDX and its competitors with MarketBeat's FREE daily newsletter. Email Address America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. REDX Media Mentions By Week REDX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REDX News Sentiment▼-0.210.57▲Average Medical News Sentiment REDX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REDX Articles This Week▼00▲REDX Articles Average Week Get Redx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for REDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: e-therapeutics News Poolbeg Pharma News Arecor Therapeutics News Scancell News C4X Discovery News OKYO Pharma News Sareum News Hemogenyx Pharmaceuticals News Destiny Pharma News Oncimmune News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:REDX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Redx Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
